Conquering the Cancer Care Continuum

As a nurse practitioner and a researcher whose focus is on supportive care in cancer, many of my patients and their caregivers look to me for answers to their questions regarding over-the-counter (OTC) supplements and prescription drugs used to treat various disorders.
This issue focuses on current good manufacturing practice (cGMP) and includes articles written by a clinical oncology pharmacist, an oncology nurse practitioner, and a regulatory lawyer.
When I joined the faculty of the McWhorter School of Pharmacy (MSOP) at Samford University in Birmingham, Alabama, in July of 2008, I was excited to discover a corporate spirit and passion for involvement with underserved populations that were similar to that of my own.
The state of healthcare in 2014 necessitates that patients play an active role in the management of their health. But who, among Americans, has access to healthcare?
As an oncology pharmacist in an ambulatory cancer clinic, in the course of a typical week, it is not unusual for me to counsel 25 to 30 new patients on chemotherapy regimens that they are about to receive (paying particular attention to adverse events [AEs]), and to be directly involved in the monitoring and management of countless other patients who present with side effects associated with their treatments.
Among the various types of treatment that a patient with cancer may undergo, chemotherapy is associated with the greatest concerns with respect to side effects.
Page 2 of 2
Results 11 - 18 of 18

Subscribe Today!

To sign up for our print publication or e-newsletter, please enter your contact information below.

I'd like to receive:

  • First Name *
    Last Name *
     
     
    Profession or Role
    Primary Specialty or Disease State
    Country